Q-Core targets ambulatory pump technology at US & EU markets
This article was originally published in Clinica
Executive Summary
Israeli pump technology specialist Q-Core (Ramat Gan) is targeting the launch of its AP 34-M multi-therapy infusion pump and EF 34-M enteral feeding pump in the US and EU markets this year. The products, based on Q-Core's proprietary electromagnetic flow control (EFC) technology, include software-controlled pump and valve technology and are designed to answer the growing need to reduce capital costs while enhancing patients' quality-of-life by treating them at alternative sites to hospitals.